Quetiapine
Product Images NDC 10135-659
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 10135-659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse (study 3) (Quetiapine Extended Release 02)
Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 9) (Quetiapine Extended Release 03)
Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 10) (Quetiapine Extended Release 04)
Principal Display Panelndc 10135-0656-60quetiapine Extended-release Tablets, Usp150 mg Once Daily60 Tabletsrx Only (Quetiapine Extended Release 05)
Principal Display Panelndc 10135-0657-60quetiapine Extended-release Tablets, Usp200 mg Once Daily60 Tabletsrx Only (Quetiapine Extended Release 06)
Principal Display Panelndc 10135-0658-60quetiapine Extended-release Tablets, Usp300 mg Once Daily60 Tabletsrx Only (Quetiapine Extended Release 07)
Principal Display Panelndc 10135-0659-60quetiapine Extended-release Tablets, Usp400 mg Once Daily60 Tabletsrx Only (Quetiapine Extended Release 08)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.